Ultrasound-guided lumpectomy of nonpalpable breast cancers: A feasibility study looking at the accuracy of obtained margins

Rahusen, Frans D.; Amerongen, Annette H. M. Taets van; Diest, Paul J. van; Borgstein, P. J.; Bleichrodt, Robert P.; Meijer, Sybren

doi:10.1002/(sici)1096-9098(199910)72:2<72::aid-jso6>3.0.co;2-m

Cited by 82 publications

(51 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The Montreal technique is safe: between January 1998 and December 2010, 9,818 such markers were deployed at our clinic, with only one case of breast infection reported.…”

Section: Montreal Techniquementioning

confidence: 99%

See 1 more Smart Citation

A plea for the biopsy marker: how, why and why not clipping after breast biopsy?

Thomassin‐Naggara

Lalonde

David

et al. 2011

Breast Cancer Res Treat

View full text Add to dashboard Cite

In the last decade, percutaneous breast biopsies have become a standard for the management of breast diseases. Biopsy clips allow for precise lesion localization, thus minimizing the volume of breast to be resected at the time of surgery. With the development of many imaging techniques (including mammography, sonography, and breast magnetic resonance imaging), one of the challenges of the multidisciplinary became to synthesize all informations obtained from the various imaging procedures. The use of biopsy markers after percutaneous biopsy is one of the keys for optimal patient management, helping the radiologist to deal with multiple lesions, to insure correlation across different imaging modalities and to follow-up benign lesions, helping the oncologist by marking a tumor prior to neoadjuvant chemotherapy, helping the surgeon by facilitating preoperative needle localization, to precisely mark the margins of extensive disease and to guide intraoperative tumor resection, and helping the pathologist to insure the lesion of interest has been removed and to identify the region of interest in a mastectomy specimen. We believe biopsy clip markers should be deployed after all percutaneous interventions and present in this review the arguments to support this statement. Minimal indications for clip deployment will also be detailed.

show abstract

“…The Montreal technique is safe: between January 1998 and December 2010, 9,818 such markers were deployed at our clinic, with only one case of breast infection reported.…”

Section: Montreal Techniquementioning

confidence: 99%

“…However, these techniques often resulted in excision of a larger volume of breast because of their lack of precision [7]. In the absence of biopsy clips, clear margins were reported in only 31-62% of women after mammographically guided wire localization [8][9][10], but this number increased to 90% in the presence of biopsy clips [11].…”

Section: Introductionmentioning

confidence: 99%

A plea for the biopsy marker: how, why and why not clipping after breast biopsy?

Thomassin‐Naggara

Lalonde

David

et al. 2011

Breast Cancer Res Treat

View full text Add to dashboard Cite

show abstract

“…77 The benefits of IOUS in the management of palpable breast cancer have been demonstrated. 80 The COBALT trial, 80 87 was included in the meta-analysis 77 and the remaining cohort-controlled studies had differences in potential confounding factors between groups. 77 Therefore, the risk of selection bias towards less-defined in situ malignancy being excluded from the IOUS group and the WGL group were not identified.…”

Section: Clinical Evidencementioning

confidence: 99%

Surgical treatment of nonpalpable primary invasive and in situ breast cancer

et al. 2015

View full text Add to dashboard Cite

Breast cancer is the most-common cancer among women worldwide, and over one-third of all cases diagnosed annually are nonpalpable at diagnosis. The increasingly widespread implementation of breast-screening programmes, combined with the use of advanced imaging modalities, such as magnetic resonance imaging (MRI), will further increase the numbers of patients diagnosed with this disease. The current standard management for nonpalpable breast cancer is localized surgical excision combined with axillary staging, using sentinel-lymph-node biopsy in the clinically and radiologically normal axilla. Wire-guided localization (WGL) during mammography is a method that was developed over 40 years ago to enable lesion localization preoperatively; this technique became the standard of care in the absence of a better alternative. Over the past 20 years, however, other technologies have been developed as alternatives to WGL in order to overcome the technical and outcome-related limitations of this technique. This Review discusses the techniques available for the surgical management of nonpalpable breast cancer; we describe their advantages and disadvantages, and highlight future directions for the development of new technologies.

show abstract

“…2 Intraoperative US-guided excisional biopsy (IUGE) is feasible for treatment of nonpalpable breast lesions, providing an accurate diagnosis and obviating wire-localization breast biopsy. [12][13][14][15] Recently, directional vacuum-assisted breast biopsy (DVAB) (with an 11-/14-gauge needle) has been recommended for the diagnosis of small lesions. 16 -18 The aim of this study was to compare the diagnostic accuracy, efficacy, and duration of IUGE and DVAB for nonpalpable breast tumors.…”

mentioning

confidence: 99%

Intraoperative Ultrasonographically Guided Excisional Biopsy or Vacuum-Assisted Core Needle Biopsy for Nonpalpable Breast Lesions

Chen¹,

Yang²,

Hwang³

et al. 2003

Annals of Surgery

View full text Add to dashboard Cite

show abstract

Ultrasound-guided lumpectomy of nonpalpable breast cancers: A feasibility study looking at the accuracy of obtained margins

Cited by 82 publications

References 16 publications

A plea for the biopsy marker: how, why and why not clipping after breast biopsy?

A plea for the biopsy marker: how, why and why not clipping after breast biopsy?

Surgical treatment of nonpalpable primary invasive and in situ breast cancer

Intraoperative Ultrasonographically Guided Excisional Biopsy or Vacuum-Assisted Core Needle Biopsy for Nonpalpable Breast Lesions

Contact Info

Product

Resources

About